Free Trial
NASDAQ:SPRC

SciSparc (SPRC) Stock Price, News & Analysis

SciSparc logo
$0.27 +0.03 (+12.42%)
(As of 11/21/2024 ET)

About SciSparc Stock (NASDAQ:SPRC)

Key Stats

Today's Range
$0.23
$0.28
50-Day Range
$0.21
$0.31
52-Week Range
$0.21
$14.22
Volume
1.82 million shs
Average Volume
1.58 million shs
Market Capitalization
$2.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.

SciSparc Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
2nd Percentile Overall Score

SPRC MarketRank™: 

SciSparc scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for SciSparc.

  • Price to Book Value per Share Ratio

    SciSparc has a P/B Ratio of 0.02. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.78% of the float of SciSparc has been sold short.
  • Short Interest Ratio / Days to Cover

    SciSparc has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SciSparc has recently increased by 7.90%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    SciSparc does not currently pay a dividend.

  • Dividend Growth

    SciSparc does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.78% of the float of SciSparc has been sold short.
  • Short Interest Ratio / Days to Cover

    SciSparc has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in SciSparc has recently increased by 7.90%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    Only 1 people have searched for SPRC on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, SciSparc insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.52% of the stock of SciSparc is held by insiders.

  • Percentage Held by Institutions

    Only 25.06% of the stock of SciSparc is held by institutions.

  • Read more about SciSparc's insider trading history.
Receive SPRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SciSparc and its competitors with MarketBeat's FREE daily newsletter.

SPRC Stock News Headlines

SciSparc Ltd. Reports Changes in Financial Position
SciSparc Ltd. Reschedules Annual General Meeting
This Bull Market Indicator called NVDA at $116
Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…
SciSparc Ltd. Gains Shareholder Approval for Proposals
See More Headlines

SPRC Stock Analysis - Frequently Asked Questions

SciSparc's stock was trading at $4.88 at the beginning of 2024. Since then, SPRC shares have decreased by 94.4% and is now trading at $0.2715.
View the best growth stocks for 2024 here
.

SciSparc's stock reverse split before market open on Thursday, September 28th 2023. The 1-26 reverse split was announced on Thursday, September 28th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of SPRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that SciSparc investors own include Solid Power (SLDP), Sangamo Therapeutics (SGMO), Plug Power (PLUG), Mullen Automotive (MULN), NVIDIA (NVDA), Verb Technology (VERB) and Avalon GloboCare (ALBT).

Company Calendar

Today
11/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SPRC
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.88 million
Book Value
$13.57 per share

Miscellaneous

Free Float
10,200,000
Market Cap
$2.47 million
Optionable
Not Optionable
Beta
0.63
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:SPRC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners